Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2026:2975:47-65.
doi: 10.1007/978-1-0716-4811-7_4.

Manual Immunofluorescence Staining for Dystrophin and Key Dystrophin-Associated Proteins

Affiliations

Manual Immunofluorescence Staining for Dystrophin and Key Dystrophin-Associated Proteins

Hui Meng et al. Methods Mol Biol. 2026.

Abstract

The detection of dystrophin and the proteins of the dystrophin-associated protein complex (DAPC) by immunostaining allows for the detection of the presence and localization of these proteins in slide-mounted sections of skeletal muscle or heart tissue. This technique has been used historically for the diagnosis and characterization of muscle disorders including Duchenne muscular dystrophy and many of the limb girdle and congenital muscular dystrophies. The extensive usefulness of this technique has allowed the development of numerous antibodies that can be used in immunostaining assays. As an increasing number of research and translational science studies have recently focused on the restoration of dystrophin as a therapeutic strategy, high-quality immunostaining techniques and analysis remain sought-after scientific practices. This chapter describes useful procedures to perform the immunofluorescence staining for dystrophin and several other useful DAPC proteins, while also providing guidance based on our clinical diagnostic and translational science research experience from working in the muscular dystrophy field.

Keywords: DAPC; Dystrophin; Histology; Immunohistochemistry; Immunostaining; Pathology; Procedure.

PubMed Disclaimer

References

    1. Ohlendieck K, Campbell KP (1991) Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice. J Cell Biol 115:1685–1694 - DOI - PubMed
    1. Shahnoor N, Siebers EM, Brown KJ et al (2019) Pathological issues in dystrophinopathy in the age of genetic therapies. Annu Rev Pathol 14:105–126 - DOI - PubMed
    1. Voit T, Stuettgen P, Cremer M et al (1991) Dystrophin as a diagnostic marker in Duchenne and Becker muscular dystrophy. Correlation of immunofluorescence and western blot. Neuropediatrics 22:152–162 - DOI - PubMed
    1. Hakim CH, Burke MJ, Teixeira J et al (2023) Histological assessment of gene therapy in the canine DMD model. Methods Mol Biol 2587:303–338 - DOI - PubMed
    1. Lawlor MWS, Childers MK, Brown KJ (2019) Histological and biochemical evaluation of muscle gene therapy. In: Duan DMJR (ed) Muscle gene therapy, 2nd edn. Springer, pp 207–226 - DOI

MeSH terms

LinkOut - more resources